BCL3 and allergic asthma: Since it was already shown that Bcl-3 is a negative regulator for IL-10 [91], these results indicate that Bcl-3 is a critical inhibitor of IL-10 in allergic asthma and targeting the Bcl-3/IL-10 axis may be a promising approach for allergic asthma therapy [103].